| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/11/2001 | CA2750854A1 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | CA2378324A1 Recombinant adenovirus |
| 01/10/2001 | EP1067179A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/10/2001 | EP1066395A1 Inducible alphaviral gene expression system |
| 01/10/2001 | EP1066391A2 Antigen preparation and use |
| 01/10/2001 | EP1066372A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
| 01/10/2001 | EP1066319A1 Production methods and uses of a retrovirus |
| 01/10/2001 | EP1066221A2 Vectors and viruses used in gene therapy |
| 01/10/2001 | CN1279723A Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 01/10/2001 | CN1279285A Broad-spectrum efficient septic cypovirus (CPV) and its bioinsecticide |
| 01/09/2001 | US6171854 Yellow fever infectious cDNA and plasmids |
| 01/09/2001 | US6171777 Decontaminating by contacting with compound, then recovering product; deactivates human immunodeficiency and hepatitis viruses; before transfusions or clinical tests |
| 01/09/2001 | US6171597 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 01/09/2001 | US6171591 Recombinant nodavirus compositions and methods |
| 01/04/2001 | WO2001000846A2 Linoleate isomerase |
| 01/04/2001 | WO2001000648A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | WO2001000234A2 Methods and compositions for engineering of attenuated vaccines |
| 01/04/2001 | WO2000061611A3 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/04/2001 | WO2000058444A3 Adaptation of virus to vertebrate cells |
| 01/04/2001 | WO2000057909A3 Attenuated dengue-2 virus vaccine |
| 01/04/2001 | WO2000053788A3 Compositions and methods for recombinant adeno-associated virus production |
| 01/04/2001 | WO2000039302A3 Improved expression of hiv polypeptides and production of virus-like particles |
| 01/04/2001 | WO2000008131A8 Pseudotyped retroviruses and stable cell lines for their production |
| 01/04/2001 | CA2377473A1 Linoleate isomerase |
| 01/04/2001 | CA2377084A1 Methods and compositions for engineering of attenuated vaccines |
| 01/04/2001 | CA2370517A1 Stabilized viral envelope proteins and uses thereof |
| 01/03/2001 | EP1064952A2 Methods and compositions for the suppression of neu mediated transformations |
| 01/03/2001 | EP1064393A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 01/03/2001 | EP1064363A1 Retroviral packaging cell line |
| 01/03/2001 | EP1064358A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 01/03/2001 | EP1064305A1 Recombinant virus |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/02/2001 | US6169109 Mixing one of a novel class of psoralen photosensitizers with said solution and irradiating the mixture |
| 01/02/2001 | US6168953 Increasing efficiency of viricide in host cell by contacting with vector derived from spumavirinae, spumavirus, lentivirinae, or lentivirus; vector contains a cis-acting genetic element which colocalizes the viricide with target |
| 01/02/2001 | US6168944 Culturing on microcarriers until confluent, transferring by trypsinizing and adding more carriers, infecting with virus, separating cells from carriers using device, liberating virus using mechanical shearing; for gene therapy |
| 01/02/2001 | US6168943 Methods for making modified recombinant vesiculoviruses |
| 01/02/2001 | US6168942 Attenuated forms of bovine viral diarrhea virus |
| 01/02/2001 | US6168941 Preparing viral plasmid cultures; culturing cells, perfusing cultures with fresh nutrients, incubate and infect cells with plasmids, replicate and recover plasmids |
| 01/02/2001 | US6168915 Mixed cell diagnostic systems |
| 12/28/2000 | WO2000078987A1 Vector for expressing two foreign genes |
| 12/28/2000 | WO2000053729A3 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 12/28/2000 | WO2000050051A3 Reovirus for the treatment of cellular proliferative disorders |
| 12/28/2000 | WO2000046355B1 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 12/28/2000 | WO2000030667A3 Compositions and methods using lactadherin or variants thereof |
| 12/28/2000 | CA2375880A1 A vector for the expression of two foreign genes |
| 12/27/2000 | EP1062614A1 Methods for making character strings, polynucleotides and polypeptides |
| 12/27/2000 | EP1062328A1 Suicide gene therapy system for the treatment of brain tumours |
| 12/27/2000 | EP1062325A2 Purification of virus preparations |
| 12/27/2000 | EP1062324A2 Medium and method for viral propagation and growth |
| 12/27/2000 | EP1062235A2 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 12/27/2000 | CN1278302A Adenovirus vectors and method for reducing homologous recombination phnomena |
| 12/27/2000 | CN1278301A Procine circoviruses, vaccines and diagnostic reagents |
| 12/26/2000 | US6165782 Nucleotide sequences for the transfer of heterologous nucleotide sequences to cells and biosynthesis of transcripts and heterologous proteins |
| 12/26/2000 | US6165773 Methods of preserving viruses |
| 12/26/2000 | US6165772 Simple and cost-effective preparation of vehicle for delivery of dna, rna, protein, peptide nucleic acids, or lipophilic drugs |
| 12/26/2000 | US6165711 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality |
| 12/21/2000 | WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/21/2000 | WO2000077216A2 Porcine circovirus vaccine in recombinant poxvirus |
| 12/21/2000 | WO2000077177A2 Isolation of a human retrovirus |
| 12/21/2000 | WO2000076540A2 Streptococcus pneumoniae proteins and vaccines |
| 12/21/2000 | WO2000076538A1 Feline calicivirus isolated from cat urine and vaccines thereof |
| 12/21/2000 | WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 12/21/2000 | WO2000052187A3 Enhanced system for construction of adenovirus vectors |
| 12/21/2000 | WO2000042068A3 Hiv related peptides |
| 12/21/2000 | WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 12/21/2000 | CA2376735A1 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 12/21/2000 | CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/20/2000 | EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 12/20/2000 | EP1060260A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
| 12/20/2000 | EP1060241A1 Preparation of cells for production of biologicals |
| 12/20/2000 | CN1277636A High efficiency vetroviral rectors that contain none of viral coding sequences |
| 12/20/2000 | CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor |
| 12/20/2000 | CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 12/19/2000 | US6162631 Retrovirus from the HIV group and its use (MVP-2901/94) |
| 12/19/2000 | US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 12/19/2000 | US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids |
| 12/19/2000 | US6162430 At least two different insecticide proteins provide synergistic control |
| 12/19/2000 | CA2203808C Hybrid adenovirus-aav virus and method of use thereof |
| 12/14/2000 | WO2000075370A1 In vivo selection method for determining inhibitory rna molecules |
| 12/14/2000 | WO2000075365A2 Compounds and methods to enhance raav transduction |
| 12/14/2000 | WO2000075353A1 Compositions and methods useful for production of recombinant viruses which require helper viruses |
| 12/14/2000 | WO2000075352A2 Hcv/bvdv chimeric genomes and uses thereof |
| 12/14/2000 | WO2000075351A1 Siv-based packaging-defficient vectors |
| 12/14/2000 | WO2000075335A2 Bacteriophage rm 378 of a thermophilic host organism |
| 12/14/2000 | WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 12/14/2000 | WO2000074722A2 Modification of biological elements |
| 12/14/2000 | WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 12/14/2000 | WO2000074483A1 Improved storage and maintenance of blood products including red blood cells and platelets |
| 12/14/2000 | CA2376790A1 Siv-based packaging-defficient vectors |
| 12/14/2000 | CA2376400A1 Compounds and methods to enhance raav transduction |
| 12/14/2000 | CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 12/14/2000 | CA2375098A1 Compositions and methods useful for production of recombinant viruses which require helper viruses |
| 12/14/2000 | CA2374664A1 In vivo selection method for determining inhibitory rna molecules |
| 12/14/2000 | CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 12/13/2000 | EP1059357A1 Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery |
| 12/13/2000 | EP0601062B2 Sirs vaccine and diagnosis method |
| 12/13/2000 | CN1059447C Polypeptide toxins from spider |
| 12/13/2000 | CN1059347C Process for preparing vaccine for hemorrhagic fever with renal syndrome |
| 12/12/2000 | US6159947 Isolation of nucleic acids and gene codes |
| 12/12/2000 | US6159728 Capsid formed from a coat protein of a bacteriophage and enclosing a foreign moiety linked to an rna sequence of a bacteriophage translational operator which binds to the coat protein; drug delivery; gene therapy |